Smart alerts aim to cut heart failure hospital stays
NCT ID NCT07412626
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding HeartLogic diagnostic alerts to usual care can reduce hospitalizations and improve quality of life for people with chronic heart failure and low ejection fraction. About 135 adults with a prior heart failure event will be enrolled. The approach uses data from implanted heart devices to guide medication adjustments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ascension St. Vincent Medical Group
Indianapolis, Indiana, 46260, United States
-
Saint Thomas Heart at Saint Thomas Midtown
Nashville, Tennessee, 37203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 30-hour e-learning course equip family doctors to deliver better palliative care?
- Heart failure drug puzzle: study aims to untangle polypharmacy risks
- Salt pills for heart failure? new study investigates
- Smartphone app may help heart failure patients get the right meds faster
- Which workout is best for heart failure? new study aims to find out
- Smart watch study aims to cut heart failure hospitalizations by 20%